
When Endometriosis Affects Your Lungs, What Can Help?
Thoracic endometriosis is rare but treatable—here’s how hormonal therapy may control bleeding and flares

If your “period symptoms” include coughing up blood
Most people think of endometriosis as pelvic pain, heavy bleeding, bowel symptoms, and fatigue. But in a small number of patients, endometriosis shows up above the diaphragm—most notably in the chest. This is called thoracic endometriosis syndrome (TES).
If you’ve ever noticed chest pain, shortness of breath, shoulder pain, or—most alarming—coughing up blood (hemoptysis) that seems to track your menstrual cycle, you deserve to be taken seriously. TES is rare, but it’s real, and delayed diagnosis is common because many clinicians simply don’t expect endometriosis to involve the lungs.
Recent clinical evidence (including long-term follow-up case data) suggests a practical, non-surgical path that may help some people: short-term ovarian suppression with a GnRH agonist (“GnRH-a”), then longer-term maintenance with dienogest.
What is thoracic endometriosis syndrome (TES) in plain language?
TES is an umbrella term for endometriosis-related problems in the chest. Symptoms often flare with hormonal cycling, especially around menstruation. TES can show up as:
- Catamenial hemoptysis (coughing up blood around your period)
- Catamenial pneumothorax (collapsed lung around your period)
- Chest/shoulder pain that predictably worsens with your cycle
- Shortness of breath or recurrent “mystery” chest symptoms that come and go monthly
You don’t need to have severe pelvic symptoms to have TES—but many people with TES do have a history of pelvic endometriosis.
The treatment approach: “shut it down, then maintain”
For TES, treatment often aims to stop hormonal stimulation of endometriosis implants so bleeding/inflammation in the chest calms down.
A strategy that may be considered (especially if surgery isn’t possible, isn’t desired, or hasn’t fully solved symptoms) is:
- GnRH-a for a limited course (in the case data: 6 courses)
- Dienogest for long-term maintenance
What these medications are (and why they’re paired)
GnRH-a (gonadotropin-releasing hormone agonist) creates a temporary, medication-induced low-estrogen state. In real life, many patients experience this as a “chemical menopause.” The goal is to rapidly reduce endometriosis activity.
Dienogest is a progestin often used for endometriosis. It can be used longer term for symptom control and is sometimes better tolerated than staying on GnRH-a.
Why combine them? Think of it as: get symptoms under control quickly (GnRH-a), then keep things stable with a longer-term option (dienogest).
How well might it work for lung-related symptoms?
If your main TES symptom is coughing up blood with your cycle, the case data behind this post is encouraging: after GnRH-a treatment followed by dienogest maintenance, hemoptysis resolved, and CT lung lesions shrank significantly, with no recurrence reported over years of follow-up.
That said, this is very important: this evidence comes from only two patients. It’s a signal of what can happen—not a guarantee of what will happen for you.
Still, if you’re sitting with frightening, cyclical respiratory symptoms and limited options, it’s meaningful to know that:
- Symptom control can be possible without chest surgery in some cases
- Long-term maintenance therapy may keep symptoms from returning
How long until you know if it’s working?
In practice, symptom-based TES often gives you an early clue: if your symptoms reliably flare with your cycle, then effective hormonal suppression often reduces or stops those cyclic flares.
A realistic way to track response is to monitor:
- Whether hemoptysis/chest symptoms occur at the next expected menstrual window
- Whether symptoms reduce in severity month-to-month
- Whether imaging (like CT findings your team is following) improves over time
Imaging changes can lag behind symptom improvement, and not everyone needs repeated CTs. But if you had visible lesions before, your clinicians may use imaging to confirm improvement.
Struggling with Chest Symptoms? Get Help
Our specialists are here to help you understand your condition and explore your treatment options.
Schedule Your ConsultSide effects: what you should realistically prepare for
GnRH-a: often effective, often rough
GnRH-a can be very effective, but side effects can be significant because estrogen drops. Common issues include hot flashes, sleep disruption, mood changes, vaginal dryness, libido changes, and (with longer use) bone density loss. Many clinicians use add-back therapy (small doses of hormone) to reduce side effects and protect bone—this is something to ask about directly.
Dienogest: often more sustainable long-term, but still not “nothing”
Dienogest is frequently used long term in endometriosis care. Some people do very well; others stop due to side effects such as irregular bleeding/spotting, mood symptoms, acne, headaches, breast tenderness, or bloating. In the long-term case experience referenced here, no significant adverse effects were reported—but again, that’s only two individuals.
If you have a history of depression/anxiety, PMDD, migraines, or severe hormonal sensitivity, it’s worth planning ahead with your clinician for close follow-up and a clear “what we’ll do if side effects show up” plan.
Who might consider this option (and who might not)?
This combined approach may be worth discussing if:
- Your symptoms strongly suggest cycle-linked TES (especially hemoptysis)
- Surgery is not available, not preferred, or you need symptom control before/after surgery
- You need a plan that is potentially long-term and fertility-sparing (meaning it doesn’t permanently remove reproductive organs), even though it does suppress ovulation while you’re on it
It may be a less good fit if:
- You cannot tolerate hormonal suppression or have had severe reactions in the past
- You have contraindications to progestins (your clinician can help determine this)
- You are actively trying to conceive right now (treatment would typically pause fertility attempts)
Practical takeaways: what to ask your doctor
Bring these questions to your next appointment (gynecology, pulmonology, or a combined team):
- “My symptoms track my cycle—could this be thoracic endometriosis syndrome?”
- “Would a short course of GnRH-a followed by dienogest maintenance make sense for me?”
- “If I use GnRH-a, will you prescribe add-back therapy to reduce side effects and protect bone?”
- “How will we measure success—symptoms only, CT imaging, or both?”
- “What side effects should make me stop the medication or call you urgently?”
- “If this doesn’t work, what are the next options—surgery, different hormones, or a referral to a TES-experienced center?”
Red flags you should not push through
TES symptoms can overlap with serious lung issues. Seek urgent care if you have significant shortness of breath, severe chest pain, fainting, or large-volume hemoptysis. Even if you strongly suspect TES, it’s still essential to rule out emergencies like pneumothorax or pulmonary embolism.
Reality check: what we still don’t know
This approach is promising—but the evidence base here is low strength (case reports). That means:
- Your outcome could be better, worse, or different
- Side effects in the real world may be more common than what two people experienced
- TES itself has different “types” (hemoptysis vs pneumothorax vs nodules), and the best treatment can vary
Also, hormones are not your only option. Some patients do best with a combined strategy (for example, surgery plus medical suppression afterward). The most important practical point is that you deserve a coordinated plan—often involving both gynecology and a chest specialist—and a way to reassess if the first attempt doesn’t meet your goals.
References
Tang, Jia, Chen, Wei, Ma, Chen. Case Report: Long-term maintenance of GnRH-a combined with dienogest for thoracic endometriosis syndrome. Frontiers in Medicine. 2025.. DOI: 10.3389/fmed.2025.1670495
Quick Answers
How rare is endosalpingiosis?
Endosalpingiosis is generally considered uncommon, but “how rare” it is depends heavily on who’s being studied and how it’s found. Many cases are discovered incidentally on pathology—meaning tissue is identified under the microscope after surgery done for other reasons—so it’s likely underrecognized in the general population. In other settings (like surgical cohorts), it may appear more often simply because more tissue is being sampled and examined carefully.
What matters most for patients is that endosalpingiosis can be confused with endometriosis on imaging or even at surgery, yet it doesn’t always behave the same way clinically. If you’ve been told you have endosalpingiosis and you also have pelvic pain, bowel/bladder symptoms, or fertility concerns, our team can help interpret what that finding means in the context of your symptoms and operative/pathology reports. You’re welcome to explore our educational content on related endometriosis and uterine conditions, and reach out to schedule a consultation if you want a personalized plan.
Can endometriosis cause arthritis-like joint pain?
Yes—endometriosis can be associated with arthritis-like joint pain in some people, even though joint pain isn’t considered a classic “core” symptom. Endometriosis can drive chronic inflammation and immune dysregulation, and that whole-body inflammatory state may show up as aching, stiffness, or flares that feel similar to inflammatory arthritis. Some patients also notice joint symptoms that cycle with their period or worsen during broader endometriosis flares.
At the same time, endometriosis doesn’t “equal” autoimmune arthritis, and an association doesn’t prove that one causes the other. Research suggests higher rates of certain autoimmune conditions in people with endometriosis—including inflammatory diseases that can affect joints—so persistent joint pain deserves a full-picture evaluation rather than being automatically attributed to pelvic disease alone. If you’re dealing with pelvic pain plus joint symptoms, our team can help you sort out what fits endometriosis, what may be a related immune condition, and how that affects your treatment plan, including whether excision surgery and coordinated integrative support make sense for you.
How does estrogen affect the endometrium?
Estrogen is one of the main hormones that drives endometrial growth. In the first half of the menstrual cycle, rising estrogen signals the endometrium to thicken and rebuild after a period, preparing the uterus for a possible pregnancy. It also influences the local immune and inflammatory environment in the uterus, which is part of why hormonal shifts can change bleeding patterns and pain.
When estrogen’s growth signals are strong—and progesterone’s “calming” effect is weaker than expected (often described as progesterone resistance)—the endometrium can behave in a more persistently inflamed, reactive way. This hormone–inflammation pattern is especially relevant in estrogen-dependent conditions like adenomyosis and endometriosis, where tissue similar to the endometrium can contribute to ongoing symptoms. If you’re trying to make sense of heavy bleeding, severe cramping, or cycle-linked pelvic pain, our team can help you connect the hormonal biology to what you’re feeling and review next steps for diagnosis and treatment.
What does a frozen uterus mean with endometriosis?
A “frozen uterus” isn’t a separate diagnosis—it’s a descriptive term surgeons use when the uterus is essentially stuck in place because endometriosis-related inflammation has caused dense scarring (adhesions). Instead of the uterus moving freely, it may be tethered to nearby structures like the bowel, bladder, ovaries, or pelvic sidewall, sometimes pulling the uterus into an abnormal position and making pelvic anatomy hard to distinguish.
This finding often suggests more advanced disease, such as deep infiltrating endometriosis and/or significant adhesions from prior inflammation or surgery, and it can help explain symptoms like deep pelvic pain, painful sex, bowel or bladder symptoms, or pain that doesn’t match what a routine exam shows. In these cases, surgery is less about “burning spots” and more about carefully restoring normal anatomy—freeing organs, protecting ureters and bowel, and removing endometriosis at its roots. If you’ve been told your uterus is “frozen,” our team can help you understand what that implies for imaging, surgical planning, and which adjacent organs may need to be evaluated as part of a complete excision strategy.
What are peritoneal pockets in endometriosis?
Peritoneal pockets are small “indentations” or fold-like defects in the peritoneum—the thin lining that covers the pelvic organs and inner abdominal wall. In endometriosis surgery, we may see these pockets as tucked-in areas or little pits in the peritoneal surface, and they can be associated with superficial peritoneal endometriosis or early/developing disease patterns.
These pockets matter because endometriosis doesn’t always look like obvious black or red implants; it can hide within subtle anatomic changes, scarring, or altered peritoneal contours. In the operating room, careful inspection and technique are important so that disease within or around a peritoneal pocket isn’t missed or only treated on the surface. If you’ve been told you have “peritoneal pockets,” our team can help you understand what that finding may mean in your case—based on your symptoms, imaging, and whether deeper structures (like bowel, bladder, or ureters) could also be involved.

